1. P136 CERTOLIZUMAB PEGOL IS EFFECTIVE IN THE MAINTENANCE OF RESPONSE IN MODERATE-SEVERE ULCERATIVE COLITIS: AN OPEN-LABEL MAINTENANCE STUDY. (18th January 2018) Authors: Osterman, Mark T; Clark-Snustad, Kindra D; Singla, Anand; Afzali, Anita; Parrott, Susan; Lee, Scott D Journal: Inflammatory bowel diseases Issue: Volume 24(2018)Supplement 1 Page Start: S49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P142 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL TO EVALUATE INDUCTION OF CLINICAL RESPONSE IN PATIENTS WITH MODERATE-SEVERE CROHN'S DISEASE TREATED WITH RIFAXIMIN. (18th January 2018) Authors: Lee, Scott D; Singla, Anand; Rulyak, Stephen J; Clark-Snustad, Kindra D Journal: Inflammatory bowel diseases Issue: Volume 24(2018)Supplement 1 Page Start: S51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗